ey0018.10-11 | (1) | ESPEYB18
H Thabit
, JN Prabhu
, W Mubita
, C Fullwood
, S Azmi
, A Urwin
, I Doughty
, L Leelarathna
Diabetes Care. 2020;43(10):25372543. doi: 10.2337/dc20-0736.This paper describes a randomized crossover trial in young people with T1D (1624 years old) comparing two 8-week study periods: the factory-calibrated Dexcom G6 CGM system versus routine self-monitoring of blood glucose (SMBG). CGM improved time within glucose target and reduced HbA1c by 0.76%.The prim...